ADITXT, INC.

Profile

Company Names

ADITXT, INC.
ADITX THERAPEUTICS, INC.

Addresses

737 N. FIFTH STREET, SUITE 200, RICHMOND, VA 23219

2569 WYANDOTTE ST., SUITE 101, MOUNTAIN VIEW, CA 94043

11161 ANDERSON STREET, SUITE 105-10014, LOMA LINDA, CA 92354

Phone Numbers

(909) 488-0844
909-488-0844

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$24,405,633.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-12-29 
$6,000,000.00 
$6,000,000.00 
$0.00 
Equity 
5
2023-09-06 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
4
2022-08-04 
$2,033,333.00 
$2,200,000.00 
$166,667.00 
Equity, Debt 
3
2021-01-25 
$6,000,000.00 
$6,000,000.00 
$0.00 
Debt 
2
2018-11-27 
$109,800.00 
$2,000,000.00 
$1,890,200.00 
Equity 
1
2018-03-17 
$262,500.00 
$2,000,000.00 
$1,737,500.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AMRO 
 
ALBANNA 
EXECUTIVE OFFICER, DIRECTOR
AVISIO, INC.   |  INNOVATION ECONOMY CORP   |  ADITX THERAPEUTICS, INC.   |  ADITXT, INC.
ROWENA 
 
ALBANNA 
EXECUTIVE OFFICER
INNOVATION ECONOMY CORP   |  ADITX THERAPEUTICS, INC.   |  ADITXT, INC.
LAURA 
E. 
ANTHONY 
DIRECTOR
ADITX THERAPEUTICS, INC.
LEONARD 
 
BAILEY 
DIRECTOR
SEKRIS BIOMEDICAL, INC.   |  ADITX THERAPEUTICS, INC.
BRIAN 
 
BRADY 
DIRECTOR
SYNCBAK, INC.   |  ADITX THERAPEUTICS, INC.   |  ADITXT, INC.
THOMAS 
 
FARLEY 
EXECUTIVE OFFICER
OPTIONS CLEARING CORP   |  ADITXT, INC.   |  ODYSSEY PRIVATE MARKETS SPV, LLC
THOMAS 
J. 
FARLEY 
EXECUTIVE OFFICER
ADITXT, INC.
NAMVAR 
 
KIAIE 
DIRECTOR
ADITX THERAPEUTICS, INC.   |  ADITXT, INC.
CHARLES 
ATHLE 
NELSON 
DIRECTOR
ADITXT, INC.
CORINNE 
 
PANKOVCIN 
EXECUTIVE OFFICER
ADITX THERAPEUTICS, INC.   |  ADITXT, INC.
JEFFREY 
 
RUNGE 
DIRECTOR
ADITXT, INC.
JEFFREY 
W. 
RUNGE 
DIRECTOR
PHARMATHENE, INC   |  CAROLINA COMPLETE HEALTH NETWORK, INC.   |  ADITX THERAPEUTICS, INC.   |  ADITXT, INC.
SHAHROKH 
 
SHABAHANG 
EXECUTIVE OFFICER, DIRECTOR
SEKRIS BIOMEDICAL, INC.   |  ADITX THERAPEUTICS, INC.   |  ADITXT, INC.
MATTHEW 
 
SHATZKES 
EXECUTIVE OFFICER
ADITXT, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-01-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-12-29 
2023-09-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-09-06 
2022-08-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-08-04 
2021-01-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-01-25 
2018-12-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2018-11-27 
2018-03-29
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2018-03-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
CRITO CAPITAL LLC
161724
NONE
NONE
NETWORK 1 FINANCIAL SECURITIES, INC.
13577
NONE
NONE
DAWSON JAMES SECURITIES, INC.
130645